James Feuille - 13 Jun 2025 Form 4 Insider Report for Chime Financial, Inc.

Reporting relationship: Director
Issuer ticker: CHYM on Nasdaq
Reported as of: 13 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Jun 2025, 19:41:34 UTC
Prior SEC filing: 11 Jun 2025
Next SEC filing: 29 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Theresa Bloom. by power of attorney

Key filing fact

James Feuille filed Form 4 for Chime Financial, Inc. on 13 Jun 2025.

Key facts

This page summarizes James Feuille's Form 4 filing for Chime Financial, Inc..
6 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 13 Jun 2025, 19:41.

Change

Previous filing in this sequence was filed on 11 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001318214 Primary reporting owner

Feuille James

Relationship: Director
Address: C/O CHIME FINANCIAL, INC., 101 CALIFORNIA STREET, SUITE 500, SAN FRANCISCO
Signature: /s/ Theresa Bloom. by power of attorney
Signature date: 13 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CHYM transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +23,766,254
Change %
Price
Shares after: 23,766,254
Date: 13 Jun 2025
Ownership: See footnote
Footnotes: F1, F2, F3, F4, F5

CHYM transaction

Common Stock

Other

Transaction value
Shares: -23,766,254
Change %: -100%
Price
Shares after: 0
Date: 13 Jun 2025
Ownership: See footnote
Footnotes: F5, F6

CHYM transaction

Class A Common Stock

Other

Transaction value
Shares: +23,766,254
Change %
Price
Shares after: 23,766,254
Date: 13 Jun 2025
Ownership: See footnote
Footnotes: F4, F5, F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CHYM transaction Derivative

Series A Preferred Stock

Conversion of derivative security

Transaction value
Shares: -16,166,706
Change %: -100%
Price
Shares after: 0
Date: 13 Jun 2025
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 16,310,624
Exercise price
Footnotes: F1, F5, F7

CHYM transaction Derivative

Series A-2 Preferred Stock

Conversion of derivative security

Transaction value
Shares: -5,069,680
Change %: -100%
Price
Shares after: 0
Date: 13 Jun 2025
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 5,069,680
Exercise price
Footnotes: F2, F5, F8

CHYM transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value
Shares: -2,385,950
Change %: -100%
Price
Shares after: 0
Date: 13 Jun 2025
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 2,385,950
Exercise price
Footnotes: F3, F5, F9

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

Each share of Series A Preferred Stock automatically converted into Common Stock on a 1.0089020772-for-1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock (the "IPO") and had no expiration date.

Footnote F2

Each share of Series A-2 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the IPO and had no expiration date.

Footnote F3

Each share of Series B Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the IPO and had no expiration date.

Footnote F4

These shares are held as follows: (i) 7,221,106 shares held by Crosslink Crossover Fund VI, L.P. ("CO VI"); (ii) 10,782,501 shares held by Crosslink Ventures VII, L.P. ("CV VII"); (iii) 4,620,340 shares held by Crosslink Ventures VII-B, L.P. ("CV VII-B"); and (iv) 1,142,307 shares held by Crosslink Bayview VII, LLC ("CB VII").

Footnote F5

The Reporting Person is: (i) a managing member of Crosslink Ventures VII Holdings, LLC, which is the general partner of CV VII and CV VII-B and the manager of CB VII; and (ii) a fund manager for Crossover Fund VI Management, L.L.C., the general partner of CO VI. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein.

Footnote F6

Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the IPO.

Footnote F7

These shares were held as follows: (i) 6,555,280 shares held by CO VI; (ii) 6,263,780 shares held by CV VII; (iii) 2,684,056 shares held by CV VII-B; and (iv) 663,590 shares held by CB VII.

Footnote F8

These shares were held as follows: (i) 2,908,030 shares held by CV VII; (ii) 1,246,100 shares held by CV VII-B; (iii) 607,470 shares held by CO VI; and (iv) 308,080 shares held by CB VII.

Footnote F9

These shares were held as follows: (i) 1,554,930 shares held by CV VII; (ii) 666,290 shares held by CV VII-B; and (iii) 164,730 shares held by CB VII.